Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials
Crossref DOI link: https://doi.org/10.1007/s13300-017-0261-8
Published Online: 2017-04-21
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sjöstrand, Mikaela
Wei, Cheryl
Cook, William
Johnsson, Kristina
Pollack, Pia S.
Stahre, Christina
Hirshberg, Boaz
Funding for this research was provided by:
AstraZeneca
Text and Data Mining valid from 2017-04-21
Article History
Received: 11 January 2017
First Online: 21 April 2017